What Lies Within

Will unlocking the secrets of the microbiome yield a promising new horizon for medicine?

10/25/2019 | Quick Read

sponsored by Quay Pharma

What does the microbiome mean for drug development? A growing number of pharmaceutical companies and biotechs are becoming interested in the trillions of microbes that live within our bodies – and how they impact our health. Microbiome research could lead to new approaches to targeting disease, either through live biotherapeutic products or traditional drug development approaches.

In this special supplement sponsored by Quay Pharma, experts from across the industry give their views on where the field of microbiome-based medicines is heading, and what the challenges will be moving forward. Featuring: Denise Kelly (Seventure), Ronnie Farquhar (Artugen Therapeutics), James Leigh (4D Pharma), Maireadh Pedersen and Ryan Wilson (Quay Pharma), James McIlroy (EnteroBiotix), Aoife Brennan (Synlogic), and Mike Romanos (Microbiotica).

Download the eBook as PDF

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.